[Parental administration of flupirtine in musculoskeletal pain. Results of a postmarket surveillance study].
Müller-Schwefe
G
G
Deutschen Gesellschaft für Schmerztherapie e. V., Schillerplatz 8/1, D-73033 Göppingen.
D000208:Acute Disease; D000631:Aminopyridines / Q000008:administration & dosage* / Q000009:adverse effects; D000700:Analgesics / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007273:Injections, Intramuscular; D008564:Membrane Potentials / Q000187:drug effects; D009474:Neurons / Q000187:drug effects; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010147:Pain Measurement; D015221:Potassium Channels / Q000187:drug effects; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors
D000631:Aminopyridines; D000700:Analgesics; D015221:Potassium Channels; D016194:Receptors, N-Methyl-D-Aspartate; C034161:flupirtine
Offene Studie mit zentral wirksamem Analgetikum. Intramuskuläre Spritze lindert akute Schmerzen und Verspannungen.